Question 1

What was the tested purity of lot HR-2026-8037?

Accepted Answer

Lot HR-2026-8037 (Cagrilintide/Retatrutide) tested at 99.870% HPLC purity from Hydro Research Peptides, based on 1 Certificate of Analysis indexed by Disclosed Labs.

Question 2

Which lab tested lot HR-2026-8037?

Accepted Answer

Lot HR-2026-8037 was tested by ILS Labs based on COA data in the Disclosed Labs corpus.

Question 3

Was lot HR-2026-8037 tested for endotoxin?

Accepted Answer

Yes — lot HR-2026-8037 has at least one COA reporting an endotoxin (LAL) result: 0.179 EU/mL. Endotoxin testing (USP <85> / LAL) is a safety panel that matters for injectable compounds.

HR-2026-8037

Tests reported